EXCLUSIVE: Senators Ask AG Bondi to Investigate If Abortion Pill Manufacturers Deceived Women

FIRST ON THE DAILY SIGNAL—Three Republican senators are asking Attorney General Pam Bondi to investigate whether drug manufacturers misrepresented the abortion pill’s safety and efficacy.

“We write to you regarding a serious public health failure that endangers countless American women,” a letter obtained by The Daily Signal reads. “In light of new data, we request an investigation into whether drug manufacturers have misrepresented mifepristone’s safety and efficacy—placing hundreds of thousands of women at risk.”

Republican Sens. Steve Daines of Montana, Marsha Blackburn of Tennessee, and Jim Banks of Indiana sent a letter to Bondi on Tuesday requesting a probe into potential criminal and civil misconduct of chemical abortion drug manufacturers. 

This comes after a study on mifepristone from the Ethics and Public Policy Center showed that women who take mifepristone suffer serious adverse events at levels 22 times greater than what is represented on the Food and Drug Administration-approved drug label.

Today, about two-thirds of abortions are through mifepristone and misoprostol.

“A person’s opinion about abortion is irrelevant,” the pro-life senators wrote. “This is a women’s health and safety issue.”

The senators urged the Justice Department to act now to protect women.

“We encourage the Department of Justice to initiate a federal investigation into the potential criminal and civil misconduct of chemical abortion manufacturers,” Daines said. “Given the breadth of the data and the implications for public health, we respectfully urge swift action to determine whether federal law was violated that compromised the safety of American women.”

Safety regulations on mifepristone were lifted in 2016 and again in 2023. The senators say the Justice Department needs to investigate what processes, if any, were followed when the safeguards on the pills were loosened.

It’s unclear whether the FDA worked with the manufacturer of Mifeprex, Danco Laboratories, in considering new data, new clinical trials, or real-world market analyses that justified reducing safety standards, the letter says.

President Donald Trump’s DOJ also needs to investigate the lack of reporting requirements on abortion pill injuries, the senators said.

“American families rely upon the FDA to protect them from harmful drugs and are, at the very least, entitled to know the real risks of the drugs they take,” the letter says. “There is no reason the FDA should waive reporting requirements when serious adverse events occur.”

“Such conduct keeps our citizens in the dark and actively works against their being able to provide informed consent,” the senators added.

If this were any other issue, Democrats would be up in arms, the trio of lawmakers wrote.

“But this issue relates to abortion, so the Democrats will do nothing. You, however, can,” they wrote to Bondi.